Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05315713
Title An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Lifespan Cancer Institute Providence Rhode Island 02905 United States Details
St Vincent's Hospital Sydney Darlinghurst New South Wales 2010 Australia Details
Eastern Health Box Hill Victoria Australia Details
St Vincent's Hospital Melbourne Fitzroy Victoria 3065 Australia Details
AZ Sint Jan Brugge Oostende AV Brugge 8000 Belgium Details
Institut Jules Bordet Bruxelles 1000 Belgium Details
AZ Groeninge Kortrijk 8500 Belgium Details
CHU UCL Namur - Mont-Godinne Yvoir 5530 Belgium Details
Tom Baker Cancer Centre-Calgary Calgary Alberta T2N 4N2 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 1Z5 Canada Details
Universitaet Duisburg-Essen Essen 45122 Germany Details
Beatson West of Scotland Cancer Centre Glasgow G12 0YN United Kingdom Details
Royal Marsden Hospital - Institute of Cancer Research - Chelsea London SE3 6JJ United Kingdom Details
Plymouth Hospitals NHS Trust - Derriford Hospital Plymouth United Kingdom Details
Royal Marsden Hospital - Institute of Cancer Research - Sutton Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field